4.0 Article

How do I/we forecast tomorrow's transfusion? A focus on recipients' profiles

Journal

TRANSFUSION CLINIQUE ET BIOLOGIQUE
Volume 30, Issue 1, Pages 27-30

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.tracli.2022.09.063

Keywords

Blood transfusion; Patient Blood Management; Artificial intelligence; Patient safety; Economics; Hospital transfusion services

Ask authors/readers for more resources

RBC transfusion plays a crucial role in the management of surgical patients, but there is a need for accurate prediction of transfusion probability due to decreasing blood donations and supply levels. Various methods, including artificial intelligence and machine learning modeling, have been established to predict the need for RBC transfusion. Predicting transfusion probability can facilitate personalized medicine, quality assurance, cost reduction, and patient safety.
Red blood cell (RBC) transfusion is a life-saving medical intervention and has an essential role in the man-agement of surgical patients. However, blood donations and supply levels are decreasing, therefore there is an unmet need for the accurate prediction of the transfusion probability for surgical patients. Multiple methods have been established to predict the need for RBC transfusion. Maximum surgical blood order schedules are widely used in the clinical setting. However, these lists are not designed to accurately pre-dict RBC utilization for an individual case as factors such as preoperative haemoglobin level, total body blood volume, comedications are not considered. Artificial intelligence and related technologies based on machine learning modelling are valuable alternatives to predict transfusion probability taking into account patient individual risk factors including among others comorbidities, laboratory parameters, use of oral anticoagulation, ASA score, surgeon's ID or applied blood saving measures. Overall, forecasting the need for a RBC transfusion can facilitate personalized medicine, quality assurance, decrease blood wastage, decrease costs, and increase patient safety. Furthermore, transfusion prediction models could facilitate blood management strategies before surgery. (c) 2022 Societe francaise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Anesthesiology

Extracorporeal membrane oxygenation in coronavirus disease 2019 A nationwide cohort analysis of 4279 runs from Germany

Benjamin Friedrichson, Jan A. Kloka, Vanessa Neef, Haitham Mutlak, Oliver Old, Kai Zacharowski, Florian Piekarski

Summary: This German study found that the hospital mortality rate was unacceptably high for COVID-19 patients receiving VV-ECMO and VA-ECMO therapy, especially among older patients. The mortality rate during the pandemic also showed an increasing trend.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2022)

Article Dermatology

Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany - a nationwide analysis

J. Kleemann, M. Meissner, D. Oezistanbullu, Ue Balaban, O. Old, S. Kippenberger, J. Kloka, R. Kaufmann, K. Zacharowski, B. Friedrichson

Summary: A study in Germany found that skin cancer cases and surgeries have persistently decreased since the beginning of the pandemic. Non-melanoma skin cancer showed a larger decrease compared to malignant melanoma, suggesting a prioritization effect. Further research is needed to understand the consequences of treatment delays and the challenges in skin cancer care.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Article Medicine, Research & Experimental

Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients - the randomized, EU-wide, placebo-controlled, phase II study design of IXION

Jan Kloka, Benjamin Friedrichson, Stephanie Dauth, Ann Christina Foldenauer, Anita Bulczak-Schadendorf, Maria J. G. T. Vehreschild, Francisco Maio Matos, Antoni Riera-Mestre, Antoinette D. van Asselt, Edoardo De Robertis, Vilma Traskaite Juskeviciene, Patrick Meybohm, Dana Tomescu, Karine Lacombe, Coen D. A. Stehouwer, Kai Zacharowski

Summary: This article introduces a research project called IXION, which aims to investigate the potential of FX06 in preventing disease progression in hospitalized, non-intubated COVID-19 patients. The clinical study will be conducted in multiple European countries, recruiting over 300 eligible patients to assess the efficacy and other parameters.

TRIALS (2022)

Article Multidisciplinary Sciences

Characteristics and mortality of 561,379 hospitalized COVID-19 patients in Germany until December 2021 based on real-life data

Jan Andreas Kloka, Lea Valeska Blum, Oliver Old, Kai Zacharowski, Benjamin Friedrichson

Summary: This study analyzed the hospitalization and ICU status of COVID-19 patients in Germany and found that 24.54% of hospitalized patients required ICU treatment, with a 33.36% mortality rate among ICU patients. The study also found that lower grades of obesity may have a protective effect on patient survival, while congestive heart failure was associated with a higher risk of death.

SCIENTIFIC REPORTS (2022)

No Data Available